436 related articles for article (PubMed ID: 6120885)
21. Pharmacological comparison of ORF 17910, a potent, long-acting histamine H2-receptor antagonist, to cimetidine and ranitidine.
Katz LB; Scott CK; Shriver DA
J Pharmacol Exp Ther; 1986 Aug; 238(2):587-93. PubMed ID: 2874214
[TBL] [Abstract][Full Text] [Related]
22. Antagonism of vasodepressor and gastric secretory responses to histamine by the H2-receptor antagonists, ranitidine and cimetidine, in the anaesthetized dog.
Daly MJ; Humphray JM; Stables R
Br J Pharmacol; 1981 Jan; 72(1):55-60. PubMed ID: 6112035
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic and gastric secretory studies of ranitidine in man.
Louis WJ; Mihaly GW; Hanson RG; Anderson A; McNeil JJ; Yeomans ND; Smallwood RA
Scand J Gastroenterol Suppl; 1981 Jun; 69():11-7. PubMed ID: 6119773
[TBL] [Abstract][Full Text] [Related]
24. Effect of BMY-25368, a potent and long-acting histamine H2-receptor antagonist, on gastric secretion and aspirin-induced gastric lesions in the dog.
Cavanagh RL; Buyniski JP
Aliment Pharmacol Ther; 1989 Jun; 3(3):299-313. PubMed ID: 2577694
[TBL] [Abstract][Full Text] [Related]
25. Effects of ORF 17583, other histamine H2-receptor antagonists and omeprazole on gastric acid secretory states in rats and dogs.
Katz LB; Tobia AJ; Shriver DA
J Pharmacol Exp Ther; 1987 Aug; 242(2):437-42. PubMed ID: 2886642
[TBL] [Abstract][Full Text] [Related]
26. A review of the animal pharmacology of ranitidine--a new, selective histamine H2-antagonist.
Brittain RT; Daly MJ
Scand J Gastroenterol Suppl; 1981 Jun; 69():1-9. PubMed ID: 6119770
[TBL] [Abstract][Full Text] [Related]
27. Effect of cimetidine on stimulated gastric secretion and serum gastrin in the dog.
Hirschowitz BI; Gibson RG
Am J Gastroenterol; 1978 Nov; 70(5):437-47. PubMed ID: 369358
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological regulation of gastric acid secretion in the apical membrane of parietal cells; a new target for antisecretory drugs.
Okabe S; Shimosako K; Amagase K
J Physiol Pharmacol; 2001 Dec; 52(4 Pt 1):639-56. PubMed ID: 11787764
[TBL] [Abstract][Full Text] [Related]
29. [Effects of a new histamine H2-receptor antagonist, ranitidine, on experimental acute gastric and duodenal ulcers (author's transl)].
Okabe S; Kunimi H; Ohtsuki H
Nihon Yakurigaku Zasshi; 1981 Apr; 77(4):397-406. PubMed ID: 6116654
[TBL] [Abstract][Full Text] [Related]
30. Kinetics of antisecretory action of a new H2-antagonist, YM-11170, in conscious dogs.
Takeda M; Takagi T; Maeno H
Eur J Pharmacol; 1983 Aug; 91(4):371-6. PubMed ID: 6137398
[TBL] [Abstract][Full Text] [Related]
31. Dynamics of gastric acid inhibition by ranitidine in duodenal ulcer patients.
Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
Digestion; 1981; 22(3):119-25. PubMed ID: 6116636
[TBL] [Abstract][Full Text] [Related]
32. Pharmacology of JB-9315, a new selective histamine H2-receptor antagonist.
Palacios B; Montero MJ; Sevilla MA; San Román L
Gen Pharmacol; 1998 Feb; 30(2):181-9. PubMed ID: 9502172
[TBL] [Abstract][Full Text] [Related]
33. Effect of nizatidine and cimetidine on betazole-stimulated gastric secretion of normal subjects: comparison of effects on acid, water, and pepsin.
Hammond JB; Offen WW
Am J Gastroenterol; 1988 Jan; 83(1):32-6. PubMed ID: 2892392
[TBL] [Abstract][Full Text] [Related]
34. The effect of the new H2-receptor antagonist mifentidine on gastric secretion, gastric emptying and experimental gastric and duodenal ulcers in the rat: comparison with cimetidine and ranitidine.
Scarpignato C; Tangwa M; Tramacere R; Del Soldato P
Digestion; 1986; 33(1):7-16. PubMed ID: 2866139
[TBL] [Abstract][Full Text] [Related]
35. Effect of a new potent H2-blocker, 3-]]]2-[(diaminomethylene)amino]-4-thiazolyl]methyl]-thio]-N2-sulfamoylpropionamidine (YM-11170) on gastric secretion induced by histamine and food in conscious dogs.
Takagi T; Takeda M; Maeno H
Arch Int Pharmacodyn Ther; 1982 Mar; 256(1):49-58. PubMed ID: 6124219
[TBL] [Abstract][Full Text] [Related]
36. Gastric acid response to topical or intravenous histamine and topical H2-receptor blockade in dogs.
Konturek SJ; Cieszkowski M; Kwiecień N; Harrison C
Agents Actions; 1981 Nov; 11(5):437-41. PubMed ID: 6121473
[TBL] [Abstract][Full Text] [Related]
37. [Effects of IT-066, a new histamine H2-receptor antagonist, on gastric acid secretion and experimental gastric ulcers in rats and dogs].
Okabe S; Nishida T; Igata H; Takagi K
Nihon Yakurigaku Zasshi; 1990 May; 95(5):247-56. PubMed ID: 1972370
[TBL] [Abstract][Full Text] [Related]
38. [Inhibition of pentagastrin-stimulated gastric secretion by ranitidine (author's transl)].
Simon B; Kather H
Dtsch Med Wochenschr; 1979 Nov; 104(47):1676-8. PubMed ID: 41699
[TBL] [Abstract][Full Text] [Related]
39. Pharmacology of mifentidine, a novel H2-receptor antagonist.
Pagani F; Micheletti R; Brambilla A; Schiavone A; Montagna E; Ciprandi C; Giachetti A
Arzneimittelforschung; 1985; 35(1A):451-5. PubMed ID: 2859036
[TBL] [Abstract][Full Text] [Related]
40. Famotidine, a new H2-receptor antagonist. Effect on parietal, nonparietal, and pepsin secretion in man.
Smith JL; Gamal MA; Chremos AN; Graham DY
Dig Dis Sci; 1985 Apr; 30(4):308-12. PubMed ID: 2858363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]